These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7987306)

  • 1. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.
    Crossey PA; Richards FM; Foster K; Green JS; Prowse A; Latif F; Lerman MI; Zbar B; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Aug; 3(8):1303-8. PubMed ID: 7987306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
    J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Clinical Research Group for VHL in Japan.
    Hum Mol Genet; 1995 Dec; 4(12):2233-7. PubMed ID: 8634692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene.
    Richards FM; Crossey PA; Phipps ME; Foster K; Latif F; Evans G; Sampson J; Lerman MI; Zbar B; Affara NA
    Hum Mol Genet; 1994 Apr; 3(4):595-8. PubMed ID: 8069305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Hippel-Lindau disease and endocrine tumour susceptibility.
    Woodward ER; Maher ER
    Endocr Relat Cancer; 2006 Jun; 13(2):415-25. PubMed ID: 16728571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
    Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
    Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic analysis of von Hippel-Lindau disease.
    Richards FM; Webster AR; McMahon R; Woodward ER; Rose S; Maher ER
    J Intern Med; 1998 Jun; 243(6):527-33. PubMed ID: 9681854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.
    Glavac D; Neumann HP; Wittke C; Jaenig H; Masek O; Streicher T; Pausch F; Engelhardt D; Plate KH; Höfler H; Chen F; Zbar B; Brauch H
    Hum Genet; 1996 Sep; 98(3):271-80. PubMed ID: 8707293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
    Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
    Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
    Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
    Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.
    Losonczy G; Fazakas F; Pfliegler G; Komáromi I; Balázs E; Pénzes K; Berta A
    BMC Med Genet; 2013 Jan; 14():3. PubMed ID: 23298237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
    Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
    Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system.
    Oberstrass J; Reifenberger G; Reifenberger J; Wechsler W; Collins VP
    J Pathol; 1996 Jun; 179(2):151-6. PubMed ID: 8758206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.